Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MZT - nee Matritech - joins Inverness:

This article was originally published in Clinica

Executive Summary

Inverness Medical Innovations has completed its acquisition of Newton, Massaschusetts-based cancer diagnostics developer Matritech. On the closing of the transaction, Matritech has changed its name to MZT Holdings and will be shortly seeking a delisting from the American Stock Exchange. Inverness, through its newly-formed subsidiary Milano Acquisitions, purchased all assets of MZT in exchange for 616,671 Inverness. Based on the Waltham, Massachusetts firm's closing price on December 12, this gave the shares a total value of $34.7m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050469

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel